|Articles|May 30, 2023

Impact of COVID-19 Variants on Symptom Severity in Infected Children

Author(s)Nina Cosdon

The Omicron variant caused the most symptoms in pediatric patients. However, there were no differences in adverse outcomes by COVID-19 variant.

Each new variant of concern that rises to dominance changes what we know about the COVID-19 virus. At the beginning of the pandemic, children were believed to be immune to symptomatic COVID-19 infection, but this was disproved by the emergence of highly virulent strains.

The symptoms and severity of COVID-19 disease are as changeable as the virus itself. One study, published in JAMA Network Open, examined whether variant type alters the symptom profiles of children infected with COVID-19.

The multicenter cohort study evaluated children in Canadian tertiary care emergency departments. The pediatric patients presented at 1 of 14 urban emergency departments between August 4, 2020-February 22, 2022.

Of the 7272 pediatric patients who presented to an emergency department, 19.8% (n = 1440) tested positive for COVID-19 and were included in this study. The cohort was 55.6% male (n = 801), and the average age was 2.0 years. Children were excluded if they were diagnosed with Kawasaki disease or multisystem inflammatory syndrome of children (MIS-C).

The primary outcomes were presence and number of COVID-19 symptoms. Secondary outcomes included presence of core COVID-19 symptoms, chest radiography findings, treatments, and 14-day outcomes.

Children infected with the Alpha variant reported the fewest core COVID-19 symptoms (195 of 237; 82.3%). The most core COVID-19 symptoms were reported by children infected with Omicron (434 of 468; 92.7%).

In a multivariable model with the original, wild-type Wuhan COVID-19 strain as the referent, the Omicron and Delta variants were more strongly correlated with fever and cough. Upper respiratory tract symptoms were associated with Delta, while lower respiratory tract and systemic symptoms were associated with Omicron.

Chest radiography and subsequent treatment were most frequent in children who contracted the Omicron variant. Omicron pediatric infections were also more likely to require intravenous fluids, corticosteroids, and emergency department visits.

The findings of this prospective observational cohort study suggest the Omicron variant caused more severe symptoms in children than other COVID-19 variants. Notably, the proportions of children admitted to the hospital and intensive care unit did not differ between variants.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.